# JNL/JPMorgan MidCap Growth Fund

JNL/JPMorgan MidCap Growth Fund is a registered fund series of JNL Series Trust (series S000001797). Net assets $3.1B as of 2026-03-31.

## Profile

- Series ID: S000001797
- Registrant: JNL Series Trust
- LEI: 1TBUGCKRNS375VJHVY86
- Net assets: $3.1B
- Total assets: $3.1B
- As of: 2026-03-31

## Advisers

- [J.P. Morgan Investment Management Inc. (Subadvisor)](https://search.stillhousedata.com/firm/107038)
- [Jackson National Asset Management, LLC (Advisor)](https://search.stillhousedata.com/firm/111079)

## Top holdings (111 reported)

_Showing 15 of 111 holdings by value._

| Holding | Ticker | Value | % of fund |
| --- | --- | --- | --- |
| [Howmet Aerospace Inc.](https://search.stillhousedata.com/security/443201108) | — | $108.6M | 348.52% |
| [Hilton Worldwide Holdings Inc.](https://search.stillhousedata.com/security/43300A203) | — | $107.2M | 344.03% |
| [Vertiv Holdings Co](https://search.stillhousedata.com/security/92537N108) | — | $105.2M | 337.78% |
| Royal Caribbean Cruises Ltd. | — | $97.2M | 312.11% |
| [Quanta Services, Inc.](https://search.stillhousedata.com/security/74762E102) | — | $90.9M | 291.64% |
| [Comfort Systems USA, Inc.](https://search.stillhousedata.com/security/199908104) | — | $80.2M | 257.43% |
| [Cencora, Inc.](https://search.stillhousedata.com/security/03073E105) | — | $78.0M | 250.43% |
| [Insmed Incorporated](https://search.stillhousedata.com/security/457669307) | — | $69.7M | 223.74% |
| [Cloudflare, Inc.](https://search.stillhousedata.com/security/18915M107) | — | $69.3M | 222.29% |
| [Alnylam Pharmaceuticals, Inc.](https://search.stillhousedata.com/security/02043Q107) | — | $63.8M | 204.75% |
| [Cheniere Energy, Inc.](https://search.stillhousedata.com/security/16411R208) | — | $54.9M | 176.23% |
| [Carvana Co.](https://search.stillhousedata.com/security/146869102) | — | $54.7M | 175.44% |
| [Burlington Stores, Inc.](https://search.stillhousedata.com/security/122017106) | — | $49.6M | 159.24% |
| [Natera, Inc.](https://search.stillhousedata.com/security/632307104) | — | $46.5M | 149.18% |
| [Neurocrine Biosciences, Inc.](https://search.stillhousedata.com/security/64125C109) | — | $43.7M | 140.40% |

## Net asset history

| Report date | Net assets |
| --- | --- |
| 2026-03-31 | $3.1B |
| 2025-12-31 | $3.4B |
| 2025-09-30 | $3.6B |
| 2025-06-30 | $3.4B |
| 2025-03-31 | $3.0B |
| 2024-12-31 | $3.3B |
| 2024-09-30 | $3.2B |
| 2024-06-30 | $3.3B |

## More

- [Registrant: JNL Series Trust](https://search.stillhousedata.com/registrant/933691)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/fund/S000001797.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.